Other studies of HNSCC/ESCC also reported that a lower concentration of CSTB increased the risks of lymph node metastasis (35, 59) and local tumor recurrence (35) and may thus result in a shorter DFS (35, 86). This evidence concerns the gene CSTB and head and neck squamous cell carcinoma.